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Background
All clinical trials that involve the prospective study of
patients need some form of independent monitoring. For
RCTs of therapeutic interventions, UK public funders of
research – including the MRC – require an independent
trial steering committee (TSC) to oversee management
and finances, and a data monitoring committee (DMC)
to oversee study progress and accumulating study data.
This fully independent TSC/DMC model may not always
be necessary for trials of tests. To address the deficit in
guidance regarding oversight arrangements, a project
funded by the MRC Midlands Hub for Trials Methodol-
ogy Research is being undertaken to investigate how
DMCs and TSCs should operate.
Aims and objectives
To develop guidance on how to select between possible
working models of TSCs and DMCs when organising
oversight procedures for trials of tests.
Methods
A review of existing guidance regarding the use of TSCs
and DMCs for trials of tests, used/published by funding
organisations around the world was carried out. A web–
based survey and structured interviews of trialists were
conducted to establish the breadth of current practice
for management and data monitoring during trials of
tests.
Results
We will provide a characterisation of how different TSC
and DMC models operate, their roles and responsibil-
ities, why particular models are selected, how models
differ according to study design, and which aspects of
the chosen working models were particularly useful/
disadvantageous.
Conclusions
Analysis of the review and survey are used to develop
insights into how particular models of TSC/DMC
should be selected when embarking upon trials of tests.
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